News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
Market source Earnings
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Rockwell Medical (RMTI) announced strong Q2 2026 results, with net sales increasing 11% year-over-year to $17.8 million and gross profit rising 30%. The company significantly narrowed its net loss to $1.2 million and generated positive operating cash flow of $2.1 million, strengthening its cash …
Rockwell Medical, Inc. (RMTI) reported its 2026 Q3 results with revenue of $17.78M, a net loss of ($1.17M), and diluted EPS of ($0.34). The company saw revenue growth driven by new Western U.S. accounts and improved gross margins due to operational efficiencies. Rockwell Medical …
Rockwell Medical (RMTI) announced an 11% increase in Q2 2026 net sales to $17.8 million and improved gross margins to 18%, narrowing its net loss. The company also executed a 1-for-10 reverse stock split on July 1, 2026, to regain Nasdaq compliance. Despite a …
The article "Rockwell Medical: Q2 Earnings Snapshot" provides a brief overview of Rockwell Medical's second-quarter earnings. The content is very minimal, indicating a lack of detailed information regarding the company's financial performance.
Rockwell Medical, Inc. (Nasdaq: RMTI) announced its financial and operational results for the second quarter and six months ended June 30, 2026, highlighting continued business momentum and progress towards its 2026 guidance. The company reported increased net sales and gross profit compared to the …
This article announces that RMTI is scheduled to report its financial results pre-market on August 13. The report will provide insight into the company's performance, which investors will be closely watching.
This article provides a comprehensive overview of Rockwell Medical, Inc. (RMTI) stock, including its current price, historical data, and key financial metrics. It details the company's operations in developing and distributing hemodialysis products and features analyst insights, including a recent price target increase by …
Rockwell Medical (RMTI) is expected to report a year-over-year increase in earnings on higher revenues for the quarter ended June 2026, though analysts have revised the EPS estimate 30% lower. The company has an Earnings ESP of 0% and a Zacks Rank of #3, …
Rockwell Medical (RMTI) has received a notice from Nasdaq regarding non-compliance with the minimum bid price requirement. In response, the company has approved a reverse stock split and analysts have significantly increased their price target to $30.00 per share, citing updated financial assumptions and …
Rockwell Medical, Inc. (A42EKB on Lang & Schwarz Exchange) reported a total revenue of €58.97 million last year, down from €97.99 million in the previous year. The majority of this revenue, €58.69 million, was generated from its Concentrate Products segment. The United States was …
This article provides a comprehensive overview of Rockwell Medical Inc.'s (RMTI) quarterly and annual cash flow statements, including operating, investing, and financing activities. It details specific financial figures such as operating cash flow, capital expenditures, and free cash flow, alongside year-over-year percentage changes. The …
This article provides a detailed revenue breakdown for Rockwell Medical Inc (RMTI), highlighting its performance by business segments and geographical regions. For the specified fiscal year, the company generated revenue primarily from Concentrate Products and Drug Products. The regional analysis indicates significant revenue contributions …
Rockwell Medical (RMTI) has regained full compliance with Nasdaq's minimum $1.00 bid price rule, ensuring its continued listing. The healthcare company, which provides hemodialysis products globally, received notification on July 16, 2026, after its shares maintained the required threshold for a period. While this …
Rockwell Medical Inc. (RMTI) is a healthcare company that develops, manufactures, and distributes hemodialysis products globally, including concentrates and other ancillary products. The company plays a significant role in sustaining dialysis patients' lives by producing products that remove toxins and balance electrolytes. Key executives …
Rockwell Medical, Inc. has announced the appointment of Brian Cox as Vice President, Quality and Regulatory Compliance. Cox brings over 20 years of experience
Rockwell Medical, Inc. announced the appointment of Brian Cox as Vice President, Quality and Regulatory Compliance, bringing over 20 years of healthcare experience from companies like Abbott and Johnson & Johnson. This strategic hire aims to strengthen the company's quality systems, regulatory capabilities, and …
Rockwell Medical, Inc. (RMTI) has announced that it has regained compliance with Nasdaq's minimum $1.00 per share bid price requirement. The company's shares maintained a closing bid price of at least $1.00 from July 1, 2026, through July 15, 2026, leading Nasdaq to close …
Rockwell Medical (NASDAQ: RMTI) has successfully regained compliance with Nasdaq's minimum bid price requirement by maintaining a closing bid price of at least $1.00 per share for the past 15 consecutive trading days. The company's shares are currently trading at $6.12, reflecting an 8% …
Rockwell Medical announced it will release its second-quarter 2026 financial results on Thursday, August 13, 2026. The announcement will be followed by a conference call and webcast that same day at 4:30 p.m. ET to discuss the financial results and provide a business update.
Rockwell Medical (Nasdaq: RMTI) announced it will release its second-quarter 2026 financial and operational results on Thursday, August 13, 2026. The company will issue a press release at 6:00 a.m. ET, followed by a live webcast at 8:00 a.m. ET, which will include a …
Search by ticker symbol or company name and select a result to open its chart.